Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 44
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Gastroenterology ; 163(4): 965-981.e31, 2022 10.
Artículo en Inglés | MEDLINE | ID: mdl-35738329

RESUMEN

BACKGROUND & AIMS: Exhaustion of CD8 T cells has been suggested to inform different clinical outcomes in Crohn's disease, but detailed analyses are lacking. This study aimed to identify the role of exhaustion on a single-cell level and identify relevant CD8 T cell populations in Crohn's disease. METHODS: Blood and intestinal tissue from 58 patients with Crohn's disease (active disease or remission) were assessed for CD8 T cell expression of exhaustion markers and their cytokine profile by highly multiplexed flow and mass cytometry. Key disease-associated subsets were sorted and analyzed by RNA sequencing. CD39 inhibition assays were performed in vitro. RESULTS: Activated CD39+ and CD39+PD-1+ CD8 T cell subsets expressing multiple exhaustion markers were enriched at low frequency in active Crohn's disease. Their cytokine production capacity was inversely linked to the Harvey-Bradshaw Index. Subset-level protein and transcriptome profiling revealed co-existence of effector and exhaustion programs in CD39+ and CD39+ PD-1+CD8 T cells, with CD39+ cells likely originating from the intestine. CD39 enzymatic activity controlled T cell cytokine production. Importantly, transcriptional exhaustion signatures were enriched in remission in CD39-expressing subsets with up-regulation of TOX. Subset-level transcriptomics revealed a CD39-related gene module that is associated with the clinical course. CONCLUSIONS: These data showed a role for the exhaustion of peripheral CD39-expressing CD8 T cell subsets in Crohn's disease. Their low frequency illustrated the utility of single-cell cytometry methods for identification of relevant immune populations. Importantly, the link of their exhaustion status to the clinical activity and their specific gene signatures have implications for exhaustion-based personalized medicine approaches.


Asunto(s)
Apirasa , Linfocitos T CD8-positivos , Enfermedad de Crohn , Apirasa/sangre , Apirasa/genética , Apirasa/inmunología , Biomarcadores/sangre , Linfocitos T CD8-positivos/inmunología , Enfermedad de Crohn/sangre , Enfermedad de Crohn/genética , Enfermedad de Crohn/inmunología , Citocinas/inmunología , Humanos , Pronóstico , Receptor de Muerte Celular Programada 1/genética , Receptor de Muerte Celular Programada 1/inmunología , Subgrupos de Linfocitos T
2.
Front Immunol ; 13: 847894, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35173744

RESUMEN

CD39/NTPDase1 has emerged as an important molecule that contributes to maintain inflammatory and coagulatory homeostasis. Various studies have hypothesized the possible role of CD39 in COVID-19 pathophysiology since no confirmatory data shed light in this regard. Therefore, we aimed to quantify CD39 expression on COVID-19 patients exploring its association with severity clinical parameters and ICU admission, while unraveling the role of purinergic signaling on thromboinflammation in COVID-19 patients. We selected a prospective cohort of patients hospitalized due to severe COVID-19 pneumonia (n=75), a historical cohort of Influenza A pneumonia patients (n=18) and sex/age-matched healthy controls (n=30). CD39 was overexpressed in COVID-19 patients' plasma and immune cell subsets and related to hypoxemia. Plasma soluble form of CD39 (sCD39) was related to length of hospital stay and independently associated with intensive care unit admission (adjusted odds ratio 1.04, 95%CI 1.0-1.08, p=0.038), with a net reclassification index of 0.229 (0.118-0.287; p=0.036). COVID-19 patients showed extracellular accumulation of adenosine nucleotides (ATP and ADP), resulting in systemic inflammation and pro-coagulant state, as a consequence of purinergic pathway dysregulation. Interestingly, we found that COVID-19 plasma caused platelet activation, which was successfully blocked by the P2Y12 receptor inhibitor, ticagrelor. Therefore, sCD39 is suggested as a promising biomarker for COVID-19 severity. As a conclusion, our study indicates that CD39 overexpression in COVID-19 patients could be indicating purinergic signaling dysregulation, which might be at the basis of COVID-19 thromboinflammation disorder.


Asunto(s)
Apirasa/sangre , Apirasa/metabolismo , COVID-19/patología , Receptores Purinérgicos P2Y/metabolismo , Tromboinflamación/patología , Adenosina Difosfato/análisis , Adenosina Trifosfato/análisis , Biomarcadores/sangre , Plaquetas/inmunología , Hipoxia de la Célula/fisiología , Cuidados Críticos/estadística & datos numéricos , Femenino , Humanos , Virus de la Influenza A/inmunología , Gripe Humana/patología , Tiempo de Internación , Masculino , Persona de Mediana Edad , Activación Plaquetaria/inmunología , Pronóstico , Estudios Prospectivos , Antagonistas del Receptor Purinérgico P2Y/farmacología , SARS-CoV-2/inmunología , Índice de Severidad de la Enfermedad , Transducción de Señal/inmunología , Tromboinflamación/inmunología , Ticagrelor/farmacología
3.
Proc Natl Acad Sci U S A ; 116(13): 6298-6307, 2019 03 26.
Artículo en Inglés | MEDLINE | ID: mdl-30846549

RESUMEN

Natural regulatory T cells (nTregs) ensure the control of self-tolerance and are currently used in clinical trials to alleviate autoimmune diseases and graft-versus-host disease after hematopoietic stem cell transfer. Based on CD39/CD26 markers, blood nTreg analysis revealed the presence of five different cell subsets, each representing a distinct stage of maturation. Ex vivo added microenvironmental factors, including IL-2, TGFß, and PGE2, direct the conversion from naive precursor to immature memory and finally from immature to mature memory cells, the latest being a no-return stage. Phenotypic and genetic characteristics of the subsets illustrate the structural parental maturation between subsets, which further correlates with the expression of regulatory factors. Regarding nTreg functional plasticity, both maturation stage and microenvironmental cytokines condition nTreg activities, which include blockade of autoreactive immune cells by cell-cell contact, Th17 and IL-10 Tr1-like activities, or activation of TCR-stimulating dendritic cell tolerization. Importantly, blood nTreg CD39/CD26 profile remained constant over a 2-y period in healthy persons but varied from person to person. Preliminary data on patients with autoimmune diseases or acute myelogenous leukemia illustrate the potential use of the nTreg CD39/CD26 profile as a blood biomarker to monitor chronic inflammatory diseases. Finally, we confirmed that naive conventional CD4 T cells, TCR-stimulated under a tolerogenic conditioned medium, could be ex vivo reprogrammed to FOXP3 lineage Tregs, and further found that these cells were exclusively committed to suppressive function under all microenvironmental contexts.


Asunto(s)
Microambiente Celular/inmunología , Linfocitos T Reguladores/inmunología , Linfocitos T Reguladores/fisiología , Apirasa/sangre , Enfermedades Autoinmunes/sangre , Enfermedades Autoinmunes/inmunología , Linfocitos T CD4-Positivos/inmunología , Citocinas/metabolismo , Células Dendríticas/inmunología , Dinoprostona/metabolismo , Dipeptidil Peptidasa 4/sangre , Factores de Transcripción Forkhead/metabolismo , Humanos , Interleucina-10/metabolismo , Interleucina-2/metabolismo , Leucemia Mieloide , Células Th17/inmunología , Factor de Crecimiento Transformador beta/metabolismo
4.
Arch Immunol Ther Exp (Warsz) ; 67(1): 49-54, 2019 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-30374518

RESUMEN

Our study aimed to study regulatory T cells (Tregs) and their expression of CD45RA, HLA-DR, and CD39 in preterm and full-term infants. In an observational study, we used a three-color flow cytometry for determination of Tregs and their expression of CD45RA, HLA-DR, and CD39 in preterm and full-term infants. The percentages of CD4+CD25+highFoxp3+, CD39+ Tregs, HLA-DR+ Tregs and the expression of Foxp3+ in CD4+CD25+highFoxp3 Tregs cells were significantly lower in neonates when compared to healthy adult controls. The levels of naïve resting Tregs (CD45RA+Tregs) were significantly higher in neonates than controls. The percentages of CD4+CD25+highFoxp3+Tregs, total CD4+CD25+ and CD4+CD25+high were significantly higher in preterm infants when compared to the full-term group. Moreover, CD45RA+Tregs were significantly higher in preterm than in term infants. We found significant inverse correlations between the gestational age and the levels of both Tregs (r = - 0.395, p = 0.017) and CD45RA+Tregs (r = - 0.422, p = 0.010). Relative to full-term, the frequencies, and phenotypes of Tregs were affected by prematurity. A larger longitudinal study with a sufficient number of newborns is needed to investigate the Treg pool of term and preterm infants thoroughly and to explore the association between the Treg pool and clinical variables.


Asunto(s)
Sangre Fetal/inmunología , Recien Nacido Prematuro/inmunología , Linfocitos T Reguladores/inmunología , Nacimiento a Término/inmunología , Apirasa/sangre , Apirasa/inmunología , Biomarcadores/sangre , Recuento de Linfocito CD4 , Estudios de Casos y Controles , Femenino , Sangre Fetal/citología , Citometría de Flujo , Edad Gestacional , Antígenos HLA-DR/sangre , Antígenos HLA-DR/inmunología , Humanos , Inmunofenotipificación/métodos , Recién Nacido , Recien Nacido Prematuro/sangre , Antígenos Comunes de Leucocito/sangre , Antígenos Comunes de Leucocito/inmunología , Masculino , Fenotipo , Estudios Prospectivos , Linfocitos T Reguladores/clasificación , Nacimiento a Término/sangre
5.
Int J Rheum Dis ; 21(8): 1548-1556, 2018 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-30146748

RESUMEN

AIM: Nearly one-third of patients with rheumatoid arthritis (RA) do not respond to Methotrexate (MTX), the first-line therapy in RA. CD39, an ectonucleotidase highly expressed on regulatory T cells (Tregs), is responsible for production of adenosine, an important anti-inflammatory mediator of MTX action. Higher expression of CD39 on Tregs improves their suppressive capacity. Therefore, we aimed to study the role of CD39+ Treg frequency as a biomarker for MTX treatment response in RA. METHODS: Patients with active RA who were naive to disease-modifying anti-rheumatic drugs were enrolled. Frequencies of CD39+ Tregs (CD4+ CD25+ FoxP3+ CD39+ cells) and CD4+ CD25+ CD39+ cells were determined by flow cytometry in peripheral blood before the start of therapy. After 4 months of MTX monotherapy, patients were classified into responders (European League Against Rheumatism [EULAR] good/moderate response) and non-responders (EULAR no response). All samples were genotyped for single nucleotide polymorphisms (SNPs) rs11188513 and rs7071836 in the ENTPD1 (CD39) gene. RESULTS: After 4 months of MTX monotherapy, 54 patients were classified as responders and 16 as non-responders. The baseline CD39+ Treg and CD4+ CD25+ CD39+ cell frequencies were significantly higher in the responder group as compared with the non-responder group (P < 0.05 and P < 0.01, respectively). AA genotype at SNP rs7071836 was associated with poor response to MTX (P < 0.05; odds ratio = 5.67; 95% CI = 1.12-28.75). CONCLUSION: Higher frequencies of CD39+ Tregs and CD4+ CD25+ CD39+ cells in the peripheral blood are associated with response to MTX in RA and hence, these could be considered as potential biomarkers for prediction of response to MTX treatment.


Asunto(s)
Antirreumáticos/uso terapéutico , Apirasa/sangre , Artritis Reumatoide/tratamiento farmacológico , Metotrexato/uso terapéutico , Linfocitos T Reguladores/efectos de los fármacos , Adulto , Apirasa/genética , Artritis Reumatoide/sangre , Artritis Reumatoide/diagnóstico , Artritis Reumatoide/inmunología , Biomarcadores Farmacológicos/sangre , Recuento de Linfocito CD4 , Monitoreo de Drogas/métodos , Femenino , Citometría de Flujo , Humanos , Masculino , Persona de Mediana Edad , Pruebas de Farmacogenómica , Variantes Farmacogenómicas , Polimorfismo de Nucleótido Simple , Linfocitos T Reguladores/inmunología , Linfocitos T Reguladores/metabolismo , Resultado del Tratamiento
6.
Platelets ; 29(8): 801-810, 2018 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-29090621

RESUMEN

Signaling mediated by purines is a widespread mechanism of cell-cell communication related to vasomotor responses and the control of platelet function in the vascular system. However, little is known about the involvement of this signaling as well as the role of reactive oxygen species (ROS) in the development of hypothyroidism. Therefore, the present study investigates changes in the purinergic system, including enzyme activities and expression in platelets, and oxidative profiles in patients with post-thyroidectomy hypothyroidism. The nucleoside triphosphate diphosphohydrolase 1 (NTPDase/CD39) expression in patients increased by 40%, and the adenosine triphosphate (ATP) or adenosine diphosphate (ADP) hydrolyzing activity increased by 82% and 70%, respectively. The activities of ecto-5´-nucleotidase and adenosine deaminase (ADA) also significantly enhanced (39% and 52%, respectively), which correlates with a 45% decrease in adenosine concentration. Furthermore, these patients demonstrated an increased production of ROS (42%), thiobarbituric acid reactive substances (TBARS) (115%), carbonyl protein (30%) and a decreased glutathione S-transferase (GST) activity (20%). This study demonstrates that hypothyroidism interferes with adenine nucleoside and nucleotide hydrolysis and this is correlated with oxidative stress, which might be responsible for the increase in ADA activity. This increase causes rapid adenosine deamination, which can generate a decrease in their concentration in the systemic circulation, which can be associated with the development of vascular complications.


Asunto(s)
Apirasa/sangre , Plaquetas/enzimología , Regulación Enzimológica de la Expresión Génica , Hipotiroidismo/sangre , Especies Reactivas de Oxígeno/sangre , Tiroidectomía , Adenosina Difosfato/sangre , Adenosina Trifosfato/sangre , Adulto , Anciano , Plaquetas/patología , Femenino , Humanos , Hipotiroidismo/etiología , Hipotiroidismo/patología , Masculino , Persona de Mediana Edad
7.
J Crohns Colitis ; 11(9): 1113-1123, 2017 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-28472257

RESUMEN

OBJECTIVE: Recent studies have suggested that the enteric nervous system can modulate gut immunity. Ecto-nucleoside triphosphate diphosphohydrolases [E-NTPDases] regulate purinergic signalling by sequential phosphohydrolysis of pro-inflammatory extracellular adenosine 5'-triphosphate [ATP]. Herein, we test the hypothesis that E-NTPDases modulate gut inflammation via neuro-immune crosstalk. DESIGN: We determined expression patterns of NTPDase2 and NTPDase3 in murine and human colon. Experimental colitis was induced by dextran sodium sulphate [DSS] in genetically engineered mice deficient in NTPDase2 or NTPDase3. We compared plasma adenosine diphosphatase [ADPase] activity from Crohn's patients and healthy controls, and linked the enzyme activity to Crohn's disease activity. RESULTS: NTPDase2 and -3 were chiefly expressed in cells of the enteric nervous system in both murine and human colon. When compared with wild type, DSS-induced colitis was exacerbated in Entpd2, and to a lesser extent, Entpd3 null mice as measured by disease activity score and histology, and marked anaemia was seen in both. Colonic macrophages isolated from Entpd2 null mice displayed a pro-inflammatory phenotype compared with wild type. In human plasma, Crohn's patients had decreases in ADPase activity when compared with healthy controls. The drop in ADPase activity was likely associated with changes in NTPDase2 and -3, as suggested by inhibitor studies, and were correlated with Crohn's disease activity. CONCLUSIONS: NTPDase2 and -3 are ecto-enzymes expressed in the enteric nervous system. Both enzymes confer protection against gut inflammation in experimental colitis and exhibit alterations in Crohn's disease. These observations suggest that purinergic signalling modulated by E-NTPDases governs neuro-immune interactions that are relevant in Crohn's disease.


Asunto(s)
Adenosina Trifosfatasas/metabolismo , Colitis/enzimología , Colon/enzimología , Enfermedad de Crohn/enzimología , Sistema Nervioso Entérico/enzimología , Adolescente , Adulto , Animales , Apirasa/sangre , Biomarcadores/metabolismo , Estudios de Casos y Controles , Colitis/inducido químicamente , Colitis/inmunología , Colitis/patología , Colon/inmunología , Colon/patología , Enfermedad de Crohn/inmunología , Enfermedad de Crohn/patología , Sulfato de Dextran , Sistema Nervioso Entérico/inmunología , Femenino , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Persona de Mediana Edad , Adulto Joven
8.
Nephrology (Carlton) ; 22(7): 505-512, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-27517975

RESUMEN

AIM: Regulatory T cells (Treg) are important in mediating immune tolerance and outcomes of allotransplantation. CD4+ CD25+ CD39+ co-expression identifies memory Treg; CD4+ CD25- CD39+ memory T effectors. We sought to determine CD4+ CD25+/- CD39+ expression from the peripheral blood of patients with end stage renal failure, following transplantation and during episodes of acute cellular rejection. METHODS: CD4+ T cells were isolated from peripheral blood leucocytes and analysed for CD25 and CD39 expression by flow cytometry. Treg suppressive function was measured by suppression of autologous effector T-cell proliferation by Treg in co-culture. RESULTS: CD4+ CD25+/- CD39+ T-cell subsets were tracked longitudinally in the peripheral blood of 17 patients following renal transplantation. Patients with acute T-cell-mediated rejection diagnosed on biopsy had reduced CD4+ CD25+ CD39+ mTreg (P < 0.05) and CD4+ CD25- CD39+ mTeff (P < 0.01) cells compared with non-rejecting patients. CD4+ CD25+ CD39+ mTreg (P < 0.05) and CD4+ CD25- CD39+ mTeff (P = 0.057) were reduced in long-term transplant patients (>1 year) compared with non-immunosuppressed controls. Interestingly, remaining CD4+ CD25+ CD39+ mTreg in the stable transplant patients displayed more potent suppressive capacity compared with non-immunosuppressed controls (83.2% ± 3.1% vs 45.7% ± 8.0%, nTeff:Treg ratio 8:1, P < 0.01). CONCLUSION: CD4+ CD25+ CD39+ mTreg and CD4+ CD25- CD39+ mTeff in peripheral blood can be tracked in renal transplant patients. Acute cellular rejection was accompanied by reduced mTreg and mTeff. Determining changes in these T-cell subsets may help to identify patients with, or at high risk of, renal allograft rejection.


Asunto(s)
Antígenos CD/sangre , Apirasa/sangre , Rechazo de Injerto/inmunología , Subunidad alfa del Receptor de Interleucina-2/sangre , Fallo Renal Crónico/cirugía , Trasplante de Riñón/efectos adversos , Linfocitos T Reguladores/inmunología , Enfermedad Aguda , Adulto , Anciano , Aloinjertos , Biomarcadores/sangre , Estudios de Casos y Controles , Proliferación Celular , Células Cultivadas , Técnicas de Cocultivo , Femenino , Rechazo de Injerto/sangre , Rechazo de Injerto/diagnóstico , Rechazo de Injerto/tratamiento farmacológico , Supervivencia de Injerto , Humanos , Inmunosupresores/uso terapéutico , Fallo Renal Crónico/sangre , Fallo Renal Crónico/inmunología , Activación de Linfocitos , Masculino , Persona de Mediana Edad , Fenotipo , Estudios Prospectivos , Factores de Riesgo , Linfocitos T Reguladores/efectos de los fármacos , Factores de Tiempo , Tolerancia al Trasplante , Resultado del Tratamiento
9.
J Hematol Oncol ; 9(1): 77, 2016 09 01.
Artículo en Inglés | MEDLINE | ID: mdl-27585656

RESUMEN

BACKGROUND: Glioblastoma multiforme (GBM), a common primary malignant brain tumor, rarely disseminates beyond the central nervous system and has a very bad prognosis. The current study aimed at the analysis of immunological control in individual patients with GBM. METHODS: Immune phenotypes and plasma biomarkers of GBM patients were determined at the time of diagnosis using flow cytometry and ELISA, respectively. RESULTS: Using descriptive statistics, we found that immune anomalies were distinct in individual patients. Defined marker profiles proved highly relevant for survival. A remarkable relation between activated NK cells and improved survival in GBM patients was in contrast to increased CD39 and IL-10 in patients with a detrimental course and very short survival. Recursive partitioning analysis (RPA) and Cox proportional hazards models substantiated the relevance of absolute numbers of CD8 cells and low numbers of CD39 cells for better survival. CONCLUSIONS: Defined alterations of the immune system may guide the course of disease in patients with GBM and may be prognostically valuable for longitudinal studies or can be applied for immune intervention.


Asunto(s)
Glioblastoma/mortalidad , Adulto , Anciano , Antígenos CD/sangre , Apirasa/sangre , Biomarcadores/sangre , Femenino , Glioblastoma/diagnóstico , Humanos , Inmunofenotipificación/métodos , Interleucina-10/sangre , Células Asesinas Naturales , Masculino , Persona de Mediana Edad , Pronóstico , Análisis de Supervivencia , Adulto Joven
10.
Artículo en Inglés | MEDLINE | ID: mdl-27638119

RESUMEN

The aim of this study was to evaluate seric NTPDase and 5'nucleotidase activities of cattle naturally infected by Eurytrema coelomanticum, as well as to correlate them to histopathological lesions in the pancreas and the degree of parasitism. Blood samples and pancreas of 51 bovines were collected on a slaughterhouse in Southern Brazil: 33 from cattle naturally infected by E. coelomanticum (the Group A), and 18 from uninfected animals (the Group B). Infected animals showed an average of 532 parasites per pancreas. In the pancreatic histology, ducts displayed hyperplasia, stenosis, proliferation of fibrous tissue, and interstitial inflammatory infiltration of lymphocytes. The serum from infected animals showed an increase in NTPDase activity when ATP was used as substrate (P<0.001). For the ADP substrate, there was no difference between groups regarding NTPDase activity (P=0.37), as well as 5'-nucleotidase activity (P=0.27). Correlating NTPDase activity (ATP substrate) with the degree of histopathological lesions (rho=0.66, P<0.001) and the parasitic load on the pancreas (rho=0.65, P<0.001), a positive correlation was observed. Similar results were found between the degree of histopathological lesions and NTPDase activity (ADP substrate; rho=0.29, P=0.03), and 5'nucleotidase activity (rho=0.35, P=0.01). Based on the results of NTPDase and 5'nucleotidase enzymes in cattle naturally infected by E. coleomanticum, it is possible to suggest that these enzymes are involved in the modulation of inflammation, and they can act as markers of inflammatory response.


Asunto(s)
5'-Nucleotidasa/sangre , Apirasa/sangre , Enfermedades de los Bovinos/patología , Dicrocoeliidae , Inflamación/veterinaria , Páncreas/parasitología , Infecciones por Trematodos/veterinaria , Mataderos , Animales , Antígenos CD , Biomarcadores/sangre , Brasil , Bovinos , Enfermedades de los Bovinos/enzimología , Enfermedades de los Bovinos/parasitología , Inflamación/enzimología , Inflamación/patología , Linfocitos , Páncreas/patología , Carga de Parásitos , Infecciones por Trematodos/enzimología , Infecciones por Trematodos/parasitología , Infecciones por Trematodos/patología
11.
Inflamm Bowel Dis ; 21(12): 2806-14, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26332314

RESUMEN

BACKGROUND: To evaluate whether changes in expression of CD39 by regulatory T lymphocytes (Treg) impact treatment response in inflammatory bowel disease. To then define the biological role of expression of CD39 on Treg in an animal model of colitis. METHODS: A prospective study of consecutive patients commencing anti-tumor necrosis factor therapy with infliximab (IFX) or adalimumab (ADA), who were then followed for 12 months. Treatment responses were defined both symptomatically and by endoscopy showing mucosal healing. Peripheral blood Tregs were quantified by flow cytometry. Functional importance of CD39 expression by Treg was determined in an adoptive T-cell transfer model of colitis. RESULTS: Forty-seven patients (ulcerative colitis, n = 22; Crohn's disease, n = 25) were recruited; 16 patients were complete responders and 13 nonresponders to anti-tumor necrosis factor. CD39 expression by Treg was lower in active inflammatory bowel disease and increased significantly after treatment in responders (CD39Treg/total Treg; 8% at baseline to 22.5% at late time point, P < 0.001). Responders were more likely to have therapeutic drug levels and in multivariate analysis therapeutic drug levels were associated with higher expression of CD39 by FoxP3 Treg and lower frequencies of interleukin 17A expressing cells. Tregs with genetic deletion of CD39 exhibit decrements in potential to suppress intestinal inflammation in a murine (CD45RB) T-cell transfer model of colitis in vivo, when compared with wild-type Treg. CONCLUSIONS: Increased expression of CD39 by peripheral blood Treg is observed in the setting of clinical and endoscopic remission in inflammatory bowel disease. Deficiency of CD39 expression by Treg can be linked to inability to suppress experimental colitis.


Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Antígenos CD/sangre , Apirasa/sangre , Colitis Ulcerosa/inmunología , Enfermedad de Crohn/inmunología , Factores Inmunológicos/uso terapéutico , Linfocitos T Reguladores/metabolismo , Adalimumab/uso terapéutico , Adulto , Animales , Antiinflamatorios/uso terapéutico , Colitis Ulcerosa/sangre , Colitis Ulcerosa/tratamiento farmacológico , Enfermedad de Crohn/sangre , Enfermedad de Crohn/tratamiento farmacológico , Femenino , Fármacos Gastrointestinales/uso terapéutico , Humanos , Infliximab/uso terapéutico , Interleucina-17/sangre , Masculino , Ratones , Persona de Mediana Edad , Estudios Prospectivos , Inducción de Remisión , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Factor de Necrosis Tumoral alfa/inmunología , Adulto Joven
12.
Mol Cell Biochem ; 404(1-2): 221-8, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25772484

RESUMEN

Extracellular adenosine 5'-triphosphate (ATP) has significant effects on a variety of pathological conditions and it is the main physiological agonist of P2X7 purinergic receptor (P2X7R). It is known that ATP acting via purinergic receptors plays a relevant role on skin inflammation, and P2X7R is required to neutrophil recruitment in a mice model of irritant contact dermatitis (ICD).The present study investigated the effects of chemical irritant croton oil (CrO) upon ATP, ADP, and AMP hydrolysis in mice blood serum, and the potential involvement of P2X7R. The topical application CrO induced a decrease on soluble ATP/ADPase activities (~50 %), and the treatment with the selective P2X7R antagonist, A438079, reversed these effects to control level. Furthermore, we showed that CrO decreased cellular viability (52.6 % ± 3.9) in relation to the control and caused necrosis in keratinocytes (PI positive cells). The necrosis induced by CrO was prevented by the pre-treatment with the selective P2X7R antagonist A438079. The results presented herein suggest that CrO exerts an inhibitory effect on the activity of ATPDase in mouse serum, reinforcing the idea that ICD has a pathogenic mechanism dependent of CD39. Furthermore, it is tempting to suggest that P2X7R may act as a controller of the extracellular levels of ATP.


Asunto(s)
Nucleótidos de Adenina/sangre , Dermatitis por Contacto/genética , Dermatitis Irritante/genética , Receptores Purinérgicos P2X7/genética , Animales , Antígenos CD/sangre , Apirasa/sangre , Aceite de Crotón/toxicidad , Dermatitis por Contacto/sangre , Dermatitis por Contacto/patología , Dermatitis Irritante/sangre , Dermatitis Irritante/patología , Modelos Animales de Enfermedad , Humanos , Hidrólisis , Queratinocitos/efectos de los fármacos , Queratinocitos/metabolismo , Ratones , Nucleótido Desaminasas/sangre , Antagonistas del Receptor Purinérgico P2X/administración & dosificación , Receptores Purinérgicos P2X7/sangre
13.
Circ Res ; 116(7): 1206-15, 2015 Mar 27.
Artículo en Inglés | MEDLINE | ID: mdl-25645301

RESUMEN

RATIONALE: Purinergic signaling plays an important role in inflammation and vascular integrity, but little is known about purinergic mechanisms during the pathogenesis of atherosclerosis in humans. OBJECTIVE: The objective of this study is to study markers of purinergic signaling in a cohort of patients with peripheral artery disease. METHODS AND RESULTS: Plasma ATP and ADP levels and serum nucleoside triphosphate diphosphohydrolase-1 (NTPDase1/CD39) and ecto-5'-nucleotidase/CD73 activities were measured in 226 patients with stable peripheral artery disease admitted for nonurgent invasive imaging and treatment. The major findings were that ATP, ADP, and CD73 values were higher in atherosclerotic patients than in controls without clinically evident peripheral artery disease (P<0.0001). Low CD39 activity was associated with disease progression (P=0.01). In multivariable linear regression models, high CD73 activity was associated with chronic hypoxia (P=0.001). Statin use was associated with lower ADP (P=0.041) and tended to associate with higher CD73 (P=0.054), while lower ATP was associated with the use of angiotensin receptor blockers (P=0.015). CONCLUSIONS: Purinergic signaling plays an important role in peripheral artery disease progression. Elevated levels of circulating ATP and ADP are especially associated with atherosclerotic diseases of younger age and smoking. The antithrombotic and anti-inflammatory effects of statins may partly be explained by their ability to lower ADP. We suggest that the prothrombotic nature of smoking could be a cause of elevated ADP, and this may explain why cardiovascular patients who smoke benefit from platelet P2Y12 receptor antagonists more than their nonsmoking peers.


Asunto(s)
5'-Nucleotidasa/sangre , Adenosina Difosfato/sangre , Adenosina Trifosfato/sangre , Antígenos CD/sangre , Apirasa/sangre , Aterosclerosis/sangre , Enfermedad Arterial Periférica/sangre , Trombofilia/sangre , Adulto , Factores de Edad , Anciano , Anciano de 80 o más Años , Fosfatasa Alcalina/sangre , Inhibidores de la Enzima Convertidora de Angiotensina/uso terapéutico , Artefactos , Aterosclerosis/epidemiología , Biomarcadores , Enfermedad Crónica , Comorbilidad , Progresión de la Enfermedad , Utilización de Medicamentos , Femenino , Finlandia/epidemiología , Proteínas Ligadas a GPI/sangre , Humanos , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Hipertensión/sangre , Hipertensión/tratamiento farmacológico , Hipertensión/epidemiología , Hipoxia/sangre , Masculino , Persona de Mediana Edad , Modelos Cardiovasculares , Enfermedad Arterial Periférica/epidemiología , Antagonistas del Receptor Purinérgico P2Y/uso terapéutico , Factores de Riesgo , Sistemas de Mensajero Secundario , Fumar/efectos adversos , Fumar/sangre , Fumar/epidemiología , Trombofilia/epidemiología , Trombofilia/etiología
14.
BMC Cardiovasc Disord ; 13: 53, 2013 Jul 28.
Artículo en Inglés | MEDLINE | ID: mdl-23890190

RESUMEN

BACKGROUND: Ectonucleotidase plays an important role in the regulation of cardiac function by controlling extracellular levels of adenine nucleotides and adenosine. To determine the influence of ischemia-reperfusion injury on ectonucleotidase activity in coronary vascular bed, we compared the metabolic profile of adenine nucleotides during the coronary circulation in pre- and post-ischemic heart. METHODS: Langendorff-perfused rat hearts were used to assess the intracoronary metabolism of adenine nucleotides. The effects of ischemia on the adenine nucleotide metabolism were examined after 30 min of ischemia and 30 min of reperfusion. Adenine nucleotide metabolites were measured by high performance liquid chromatography. RESULTS: ATP, ADP and AMP were rapidly metabolized to adenosine and inosine during the coronary circulation. After ischemia, ectonucleotidase activity of the coronary vascular bed was significantly decreased. In addition, the perfusate from the ischemic heart contained a considerable amount of enzymes degrading ATP, AMP and adenosine. Immunoblot analysis revealed that the perfusate from the ischemic heart dominantly contained ectonucleoside triphosphate diphosphohydrolase 1, and, to a lesser extent, ecto-5'-nucleotidase. The leakage of nucleotide metabolizing enzymes from the coronary vascular bed by ischemia-reperfusion was more remarkable in aged rats, in which post-ischemic cardiac dysfunction was more serious. CONCLUSION: Ectonucleotidases were liberated from the coronary vascular bed by ischemia-reperfusion, resulting in an overall decrease in ectonucleotidase activity in the post-ischemic coronary vascular bed. These results suggest that decreased ectonucleotidase activity by ischemia may exacerbate subsequent reperfusion injury, and that levels of circulating ectonucleotidase may reflect the severity of ischemic vascular injury.


Asunto(s)
Nucleótidos de Adenina/sangre , Vasos Coronarios/enzimología , Pirofosfatasas/sangre , Daño por Reperfusión/enzimología , 5'-Nucleotidasa/sangre , Nucleótidos de Adenina/administración & dosificación , Adenosina/administración & dosificación , Adenosina/sangre , Adenosina Trifosfatasas/sangre , Envejecimiento/sangre , Animales , Antígenos CD/sangre , Apirasa/sangre , Endotelio Vascular/enzimología , Frecuencia Cardíaca/efectos de los fármacos , Técnicas In Vitro , Masculino , Nucleotidasas/sangre , Hidrolasas Diéster Fosfóricas/sangre , Ratas Wistar , Daño por Reperfusión/fisiopatología
15.
Transplantation ; 95(1): 63-9, 2013 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-23232366

RESUMEN

BACKGROUND: We have previously demonstrated that CD133 and CD39 are expressed by hematopoietic stem cells (HSC), which are mobilized after liver injury and target sites of injury, limit vascular inflammation, and boost hepatic regeneration. Plasma microparticles (MP) expressing CD39 can block endothelial activation. Here, we tested whether CD133 MP might be shed in a CD39-dependent manner in a model of liver injury and could potentially serve as biomarkers of liver failure in the clinic. METHODS: Wild-type and Cd39-null mice were subjected to acetaminophen-induced liver injury. Mice were sacrificed and plasma MP were isolated by ultracentrifugation. HSC and CD133 MP levels were analyzed by fluorescence-activated cell sorting. Patients were enrolled with acute (n=5) and acute on chronic (n=5) liver injury with matched controls (n=7). Blood was collected at admission and plasma CD133 and CD39 MP subsets were analyzed by fluorescence-activated cell sorting. RESULTS: HSC and CD133 MP levels were significantly increased only in the plasma of wild-type mice with acetaminophen hepatotoxicity (P<0.05). No increases in CD133 MP were noted in Cd39-null mice. Plasma MP increases were observed in patients with liver injury. These MP were characterized by significantly higher levels of CD39 (P<0.05). CONCLUSIONS: HSC and plasma CD133 MP levels increase in a CD39-dependent manner during experimental acute liver injury. Increased levels of CD39 MP are differentially noted in patients with liver injury. Further research is needed to determine whether MP fluxes are secondary to pathophysiologic insults to the liver or might reflect compensatory responses.


Asunto(s)
Lesión Pulmonar Aguda/sangre , Antígenos CD/sangre , Apirasa/sangre , Micropartículas Derivadas de Células/química , Glicoproteínas/sangre , Péptidos/sangre , Antígeno AC133 , Acetaminofén/toxicidad , Animales , Biomarcadores , Micropartículas Derivadas de Células/fisiología , Células Madre Hematopoyéticas/fisiología , Humanos , Interleucina-8/sangre , Hígado/efectos de los fármacos , Masculino , Ratones , Ratones Endogámicos C57BL , Factor A de Crecimiento Endotelial Vascular/sangre
16.
Biometals ; 25(6): 1195-206, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-22991071

RESUMEN

The present study aimed to investigate the influence of N-acetylcysteine (NAC) on cadmium (Cd) poisoning by evaluating Cd concentration in tissues, hematological indices as well as the activity of NTPDase, acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) enzymes of rats exposed to Cd and co-treated with NAC. For this purpose, the rats received Cd (2 mg/kg) and NAC (150 mg/kg) by gavage every other day for 30 days. Animals were divided into four groups (n = 6-8): control/saline, NAC, Cd, and Cd/NAC. Cd exposure increased Cd concentration in plasma, spleen and thymus, and NAC co-treatment modulated this augment in both lymphoid organs. Cd exposure reduced red blood cell count, hemoglobin content and hematocrit value. Cd intoxication caused a decrease in total white blood cell count. NAC treatment per se caused an increase in lymphocyte and a decrease in neutrophil counts. On contrary, Cd exposure caused a decrease in lymphocyte and an increase in neutrophil and monocyte counts. NAC reversed or ameliorated the hematological impairments caused by Cd poisoning. There were no significant alterations in the NTPDase activity in lymphocytes of rats treated with Cd and/or NAC. Cd caused a decrease in the activities of lymphocyte AChE, whole blood AChE and serum BChE. However, NAC co-treatment was inefficient in counteracting the negative effect of Cd in the cholinesterase activities. The present investigation provides ex vivo evidence supporting the hypothesis that Cd induces immunotoxicity by interacting with the lymphoid organs, altering hematological parameters and inhibiting peripheral cholinesterase activity. Also, it highlights the possibility to use NAC as adjuvant against toxicological conditions.


Asunto(s)
Acetilcolinesterasa/metabolismo , Acetilcisteína/farmacología , Antígenos CD/metabolismo , Apirasa/metabolismo , Butirilcolinesterasa/metabolismo , Cadmio/farmacología , Acetilcolinesterasa/sangre , Acetilcisteína/administración & dosificación , Animales , Antígenos CD/sangre , Apirasa/antagonistas & inhibidores , Apirasa/sangre , Butirilcolinesterasa/sangre , Cadmio/administración & dosificación , Cadmio/sangre , Linfocitos/efectos de los fármacos , Linfocitos/enzimología , Linfocitos/metabolismo , Masculino , Ratas , Ratas Wistar , Relación Estructura-Actividad
17.
Arterioscler Thromb Vasc Biol ; 31(7): 1607-16, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21512161

RESUMEN

OBJECTIVE: Hypothermia is used in various clinical settings to inhibit ischemia-related organ damage. However, prothrombotic effects have been described as potential side effects. This study aimed to elucidate the mechanism of hypothermia-induced platelet activation and subsequent prothrombotic events and to develop preventative pharmacological strategies applicable during clinically used hypothermia. METHODS AND RESULTS: Platelet function was investigated ex vivo and in vivo at clinically used hypothermia (28°C/18°C). Hypothermic mice demonstrated increased expression of platelet activation marker P-selectin, platelet-leukocyte aggregate formation, and thrombocytopenia. Intravital microscopy of FeCl(3)-injured murine mesenteric arteries revealed increased platelet thrombus formation with hypothermia. Ex vivo flow chamber experiments indicated increased platelet-fibrinogen adhesion under hypothermia. We show that hypothermia results in reduced ADP hydrolysis via reduction of CD39 (E-NTPDase1) activity, resulting in increased levels of ADP and subsequent augmented primary and secondary platelet activation. In vivo administration of ADP receptor P(2)Y(12) antagonists and recombinant soluble CD39 prevented hypothermia-induced thrombus formation and thrombocytopenia, respectively. CONCLUSIONS: The platelet agonist ADP plays a key role in hypothermia-induced platelet activation. Inhibition of receptor binding or hydrolysis of ADP has the potential to protect platelets against hypothermia-induced activation. Our findings provide a rational basis for further evaluation of novel antithrombotic strategies in clinically applied hypothermia.


Asunto(s)
Adenosina Difosfato/sangre , Plaquetas/efectos de los fármacos , Fibrinolíticos/farmacología , Hipotermia Inducida , Activación Plaquetaria/efectos de los fármacos , Inhibidores de Agregación Plaquetaria/farmacología , Trombosis/prevención & control , Análisis de Varianza , Animales , Antígenos CD/sangre , Antígenos CD/farmacología , Apirasa/sangre , Apirasa/farmacología , Plaquetas/metabolismo , Fibrinógeno/metabolismo , Humanos , Hidrólisis , Hipotermia Inducida/efectos adversos , Leucopenia/sangre , Leucopenia/etiología , Glicoproteínas de Membrana/sangre , Ratones , Ratones Endogámicos C57BL , Selectina-P/sangre , Adhesividad Plaquetaria/efectos de los fármacos , Complejo GPIb-IX de Glicoproteína Plaquetaria , Antagonistas del Receptor Purinérgico P2Y/farmacología , Receptores Purinérgicos P2Y1/sangre , Receptores Purinérgicos P2Y1/efectos de los fármacos , Receptores Purinérgicos P2Y12/sangre , Receptores Purinérgicos P2Y12/efectos de los fármacos , Proteínas Recombinantes/farmacología , Trombocitopenia/sangre , Trombocitopenia/etiología , Trombosis/sangre , Trombosis/etiología , Factor de von Willebrand/metabolismo
18.
Chronobiol Int ; 27(9-10): 1751-61, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20969521

RESUMEN

Circadian rhythms represent an important mechanism to prepare the organism for environmental variations. ATP, ADP, AMP, and adenosine can act as extracellular messengers in a range of biological processes and are metabolized by a number of enzymes, including NTPDases and 5'-nucleotidase. In the present study the authors report that ATPase and ADPase activities present 24-h temporal variations that peak during dark (activity) span. These findings suggest that this enzymatic temporal pattern in blood serum might be important for the normal physiology and function of the organism through the maintenance of extracellular nucleotides at physiological levels.


Asunto(s)
5'-Nucleotidasa/sangre , Ritmo Circadiano , Adenosina Difosfato/metabolismo , Adenosina Trifosfatasas/sangre , Adenosina Trifosfato/metabolismo , Animales , Apirasa/sangre , Corticosterona/sangre , Cinética , Masculino , Melatonina/sangre , Nucleotidasas/sangre , Ratas , Ratas Wistar
19.
Ukr Biokhim Zh (1999) ; 82(2): 59-66, 2010.
Artículo en Ucraniano | MEDLINE | ID: mdl-20684246

RESUMEN

Influence of DL-homocysteine thiolactone loading (100 mg/kg by intragastric administration for 28 days) on enzymes activity of adenylic nucleotide and adenosine metabolism in the blood serum, platelets and liver of rats was investigated. The relation between revealed disturbance and platelet hyper-reactivity was estimated. It was established, that apyrase and 5'-nucleotidase activities decreased and adenosine deaminase activity increased in platelets of the rats with hyperhomocysteinemia (HHC). HHC also interrupted adenosine production in the blood serum and liver in rats. Under this condition the platelet sensitivity to ADP-stimulation was significantly increased. Vitamin-microelement complex decreased HHC-induced disorder of adenosine metabolism and prevented platelet hyper-reactivity formation. In vitro homocysteine inhibited platelet hydrolysis of ADP and AMP in a dose-dependent manner and this effect reduced in the presence of hydrogen sulfide donor NaHS.


Asunto(s)
Adenosina/metabolismo , Homocisteína/análogos & derivados , Hiperhomocisteinemia/prevención & control , Activación Plaquetaria/efectos de los fármacos , Oligoelementos/uso terapéutico , Vitaminas/uso terapéutico , 5'-Nucleotidasa/sangre , 5'-Nucleotidasa/metabolismo , Animales , Apirasa/sangre , Apirasa/metabolismo , Modelos Animales de Enfermedad , Combinación de Medicamentos , Homocisteína/administración & dosificación , Hiperhomocisteinemia/sangre , Hiperhomocisteinemia/enzimología , Hiperhomocisteinemia/metabolismo , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/metabolismo , Masculino , Ratas , Oligoelementos/administración & dosificación , Resultado del Tratamiento , Vitaminas/administración & dosificación
20.
Biomed Pharmacother ; 64(7): 499-504, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20347573

RESUMEN

BACKGROUND: Uterine cervical neoplasia is an important worldwide malignancy sometimes associated with thrombosis. Ectonucleotidases are membrane-bound enzymes which participate in thromboregulation by hydrolyzing adenine nucleotides in the extracellular medium. In this sense, we aimed to investigate their activity in patients with uterine cervical neoplasia. METHODS: We evaluated NTPDase and 5'-nucleotidase activities from patients previously treated for uterine cervical neoplasia with either conization or radiotherapy (RTX). These patients were divided into four groups: two conization groups (I and II) and two RTX groups (III and IV), which were further divided based on the amount of time that had passed since the conclusion of their treatment, where groups I and III were extended-remission-period groups (patients with 1 to 5 years elapsed after the conclusion of treatment), and groups II and IV were recently treated patients (treated up to three months before). RESULTS: For both conization and RTX groups, ATP and ADP hydrolysis decreased in the extended-remission groups when compared to the control and recently treated groups. On the other hand, AMP hydrolysis was decreased in all the treated groups (both conization and RTX) compared to the control. CD39 expression was decreased in extended-remission groups (I and III) when compared to the other groups. CONCLUSIONS: NTPDase protects against platelet aggregation and 5'-nucleotidase is more involved in the control of adenosine formation.


Asunto(s)
Antígenos CD/sangre , Apirasa/sangre , Plaquetas/enzimología , Conización , Neoplasias del Cuello Uterino/radioterapia , Neoplasias del Cuello Uterino/cirugía , 5'-Nucleotidasa/sangre , Adenosina Difosfato/metabolismo , Adenosina Monofosfato/metabolismo , Adenosina Trifosfato/metabolismo , Adulto , Pruebas de Coagulación Sanguínea , Femenino , Humanos , Persona de Mediana Edad , Agregación Plaquetaria , Recuento de Plaquetas , Plasma Rico en Plaquetas , Neoplasias del Cuello Uterino/sangre , Neoplasias del Cuello Uterino/enzimología , Frotis Vaginal
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...